login
Password reminder
Cardiovascular News
Contact the editor Visit Cardiovascular News Twitter feed Visit Cardiovascular News Facebook page
 

Download past and current PDFs issues




 
1 - 20 of 39   Items
Cardiovascular News Issue 37 - May 2015
Cardiovascular News Issue 37 - May 2015
download now
Highlights: -In BEST, surgery is still top option for multivessel disease -Two-year data "suggest CoreValve should be preferred option for high-risk patients" -Wayne Batchelor: Closing the data gap -Martin Cowie: SERVE-HF -Profile: Deepak L Bhatt
Cardiovascular News Issue 37 - May 2015 US Edition
Cardiovascular News Issue 37 - May 2015 US Edition
download now
Highlights: -In BEST, surgery is still top option for multivessel disease -Two-year data "suggest CoreValve should be preferred option for high-risk patients" -Wayne Batchelor: Closing the data gap -Martin Cowie: SERVE-HF -Profile: Deepak L Bhatt
Cardiovascular News Issue 36 - February 2015
Cardiovascular News Issue 36 - February 2015
download now
Highlights: -More data needed for routine use of TAVI in lower risk patients -First randomised trial of Absorb indicates device has similar one-year clinical outcomes to Xience -Guillaume Cayla: DAPT duration -Leon Neething: Repairing hearts -Profile: Flavio Ribichini
Cardiovascular News Issue 36 - February 2015 US Edition
Cardiovascular News Issue 36 - February 2015 US Edition
download now
Highlights: -More data needed for routine use of TAVI in lower risk patients -First randomised trial of Absorb indicates device has similar one-year clinical outcomes to Xience -Guillaume Cayla: DAPT duration -Leon Neething: Repairing hearts -Profile: Flavio Ribichini - See more at: http://www.cxvascular.com/cn-newspaper-pdfs?Preview=1#sthash.k3KTsETY.dpuf
Cardiovascular News Issue 35 - September 2014
Cardiovascular News Issue 35 - September 2014
download now
Highlights: -European guidelines lower duration of dual antiplatelet therapy to six months or less -Fractional flow reserve is safe and feasible in NSTEMI patients -Sanjit Jolly: TASTE -Tim Fischell: Renal denervation -Profile: Sunil Rao
Cardiovascular News Issue 35 - September 2014 US Edition
Cardiovascular News Issue 35 - September 2014 US Edition
download now
Highlights: -European guidelines lower duration of dual antiplatelet therapy to six months or less -Fractional flow reserve is safe and feasible in NSTEMI patients -Sanjit Jolly: TASTE -Tim Fischell: Renal denervation -Profile: Sunil Rao
Cardiovascular News Issue 34 - August 2014
Cardiovascular News Issue 34 - August 2014
download now
Highlights: -Staged intervention is right way to treat STEMI patients with multivessel disease -No incidences of severe paravalvular leak with next-generation TAVI devices -Robert Byrne: drug-coated balloons -Ziyad M Hijazi: Congenital conditions -Profile: Azeem Latib
Cardiovascular News Issue 34 - August 2014 US Edition
Cardiovascular News Issue 34 - August 2014 US Edition
download now
Highlights: -Staged intervention is right way to treat STEMI patients with multivessel disease -No incidences of severe paravalvular leak with next-generation TAVI devices -Robert Byrne: drug-coated balloons -Ziyad M Hijazi: Congenital conditions -Profile: Azeem Latib
Cardiovascular News Issue 33 - May 2014 US Edition
Cardiovascular News Issue 33 - May 2014 US Edition
download now
Highlights: - Renal denervation comes to a "grinding halt" but studies will continue - One-year survival is significantly better with self-expanding TAVI device than with surgery - "Interventional cardiology is losing more than 50% of the talent pool" - profile: David J Cohen
Cardiovascular News Issue 33 - May 2014
Cardiovascular News Issue 33 - May 2014
download now
Highlights: - Renal denervation comes to a "grinding halt" but studies will continue - One-year survival is significantly better with self-expanding TAVI device than with surgery - "Interventional cardiology is losing more than 50% of the talent pool" - profile: David J Cohen
Cardiovascular News Issue 32 - February 2014
Cardiovascular News Issue 32 - February 2014
download now
Highlights: -Major setback for renal denervation -Long-term dual antiplatelet therapy may not always be needed -The use of vascular robotic systems for PCI, by Ronald P Caputo -Profile: Ashok Seth
Cardiovascular News Issue 32 - February 2014 US Edition
Cardiovascular News Issue 32 - February 2014 US Edition
download now
Highlights: -Major setback for renal denervation -Long-term dual antiplatelet therapy may not always be needed -The use of vascular robotic systems for PCI, by Ronald P Caputo -Profile: Ashok Seth
Cardiovascular News Issue 31 - October 2013
Cardiovascular News Issue 31 - October 2013
download now
Highlights: -Preventative angioplasty in non-infarct arteries benefits STEMI patients -PCI and bypass graft surgery: Which intervention and in whom? -Unilateral renal denervation may be feasible when bilateral approach is not possible -Profile: Thomas F Luscher
Cardiovascular News Issue 31 - October 2013 US Edition
Cardiovascular News Issue 31 - October 2013 US Edition
download now
Highlights: -Preventative angioplasty in non-infarct arteries benefits STEMI patients -PCI and bypass graft surgery: Which intervention and in whom? -Unilateral renal denervation may be feasible when bilateral approach is not possible -Profile: Thomas F Luscher
Cardiovascular News issue 30 - August 2013
Cardiovascular News issue 30 - August 2013
download now
Highlights: -Six to 12 months is the right timeframe for dual antiplatelet therapy-Questions raised about bivalirudin's superiority over heparin-How to negotiate tortuous arteries in renal denervation by Erwin Blessing -Profile: Chaim Lotan
Cardiovascular News issue 30 - August 2013 US edition
Cardiovascular News issue 30 - August 2013 US edition
download now
Highlights: -Six to 12 months is the right timeframe for dual antiplatelet therapy-Questions raised about bivalirudin's superiority over heparin-How to negotiate tortuous arteries in renal denervation by Erwin Blessing -Profile: Chaim Lotan
Cardiovascular News issue 29 - May 2013
Cardiovascular News issue 29 - May 2013
download now
Highlights: Cangrelor significantly reduces ischaemic events compared with clopidogrel; transcatheter aortic valve still works after three years in high-risk patients; novel drug could reduce heart damage during angioplasty. Profile: Morton Kern
Cardiovascular News issue 29 - May 2013 US edition
Cardiovascular News issue 29 - May 2013 US edition
download now
Highlights: Cangrelor significantly reduces ischaemic events compared with clopidogrel; transcatheter aortic valve still works after three years in high-risk patients; novel drug could reduce heart damage during angioplasty. Profile: Morton Kern
Cardiovascular News Issue 28 - February 2013
Cardiovascular News Issue 28 - February 2013
download now
Highlights: -RESPECT seen as positive despite failure to meet endpoint -Stent type may affect antiplatelet therapy duration -TAVI complications by Max Baghai -Profile: Stefan D Anker
Cardiovascular News Issue 28 - February 2013 US Edition
Cardiovascular News Issue 28 - February 2013 US Edition
download now
Highlights: -RESPECT seen as positive despite failure to meet endpoint -Stent type may affect antiplatelet therapy duration -TAVI complications by Max Baghai -Profile: Stefan D Anker
Cardiovascular News Issue 27 - October 2012
Cardiovascular News Issue 27 - October 2012
download now
Highlights: -TRILOGY-ACS shows no advantage for prasugrel over clopidogrel -Renal denervation may be cost-effective for resistant hypertension -German registry shows TAVI restricted to high-risk patients and with in-hospital mortality comparable to surgery -Profile: David Holmes

Most popular


Merit Medical Systems launches the Prelude Snap splittable sheath introducer
Wednesday, 03 Jun 2015
Merit Medical Systems has launched the Prelude Snap splittable sheath introducer, the design of which is based directly on physician feedback. Merit Medical Systems launches the Prelude Snap splittable sheath introducer

Men believe “long working hours” stop women from being interventional cardiologists
Wednesday, 15 Jul 2015
According to a new survey published in EuroIntervention, men state that the long working hours and the need to be on call that is associated with being an interventional cardiologist are the key ... Men believe “long working hours” stop women from being interventional cardiologists

Boston Scientific launches bioresorbable scaffold trial
Monday, 20 Jul 2015
Boston Scientific has initiated a study to evaluate its fully resorbable scaffold technology. FAST (Fully absorbable scaffold feasibility study) is a prospective, single-arm study designed to assess ... Boston Scientific launches bioresorbable scaffold trial

Features


Strut coverage: Optical coherence tomography and new stent technologies
Monday, 20 Jul 2015
Tim Kinnaird explores the risk of stent thrombosis with current technologies, how new technologies may be able to reduce this risk, and how OCT can help to assess this risk. Strut coverage: Optical coherence tomography and new stent technologies

The second generation of drug-eluting stents with biodegradable polymers may have potential advantages
Monday, 06 Jul 2015
Drug-eluting stents with biodegradable polymers have theoretical advantages over drug-eluting stents with permanent polymers—even second-generation drug-eluting stents. The second generation of drug-eluting stents with biodegradable polymers may have potential advantages

Profiles


Deepak L Bhatt
Tuesday, 09 Jun 2015
Deepak L Bhatt (Executive director of Interventional Cardiovascular Programs, Brigham and Women’s H... Deepak L Bhatt

Flavio Ribichini
Thursday, 05 Mar 2015
Flavio Ribichini speaks to Cardiovascular News about being involved in the first use of primary ... Flavio Ribichini

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions